The Invesco Perpetual High Income Fund aims to achieve a high level of income, together with capital growth. The fund intends to invest primarily in companies listed in the UK, with the balance invested internationally.
Name | % Net Assets |
---|---|
Novartis | 2.6% |
Roche | 2.4% |
Novartis | 1.7% |
Barclays Bank 14% £ Bonds Perp | 1.6% |
John Lewis 8.375% £ Bonds 8/4/2019 | 1.5% |
Carlsberg 7.25% £ Bonds 28/11/2016 | 1.4% |
GDF Suez | 1.4% |
ING | 1.1% |
Sanofi | 1.1% |
Atlantia | 1.0% |
Key | % Net Assets |
---|---|
Novartis | 2.6% |
Roche | 2.4% |
Novartis | 1.7% |
Barclays Bank 14% £ Bonds Perp | 1.6% |
Other | 91.7% |
Date | 19-Aug-2022 |
---|---|
NAV | 62.85p |
Currency | GBP |
Change | -0.100p |
% | -0.16% |
YTD change | 62.85p |
YTD % | n/a |
Fund Inception | 01/05/2008 |
---|---|
Fund Manager | n/a |
TER | 1.51 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.52% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research